PNK · —

IMRIS Inc. (IMRSQ) Stock

$0.00 PNK: IMRSQ

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide.

Valuation

MetricValue
Price$0.00
Market Cap
P/E Ratio0.00
P/B Ratio0.00
P/S Ratio0.00
EPS (TTM)$-0.58
52-Week High$0.00
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-250.00%
ROA-46.15%
ROCE-68.54%
Gross Margin-79.31%
Operating Margin-79.31%
Net Margin-103.45%
Debt/Equity1.92
Current Ratio1.09

Annual Financials (USD)

Metric20102011201220132014
Revenue$70.0M$52.0M$52.0M$46.0M$29.0M
Operating Profit$-1.0M$-21.0M$-28.0M$-39.0M$-23.0M
Net Profit$-2.0M$-21.0M$-28.0M$-42.0M$-30.0M
EPS$-0.04$-0.47$-0.61$-0.83$-0.58
Op Margin-1.4%-39.7%-52.5%-85.4%-80.1%

Balance Sheet (USD)

Metric20102011201220132014
Total Assets$115.0M$94.0M$82.0M$86.0M$65.0M
Total Liabilities$22.0M$20.0M$31.0M$51.0M$54.0M
Cash$61.0M$40.0M$19.0M$6.0M$5.0M
Borrowings$0$0$0$21.0M$23.0M

Cash Flow (USD)

Metric20102011201220132014
Operating Cash Flow$-14.0M$-18.0M$-16.0M$-41.0M$-11.0M
Investing Cash Flow$-4.0M$-7.0M$-13.0M$-24.0M$2.0M
Financing Cash Flow$0$0$0$-2.0M$0
Net Cash Flow$34.0M$-20.0M$-21.0M$-13.0M$-1.0M
Free Cash Flow$-16.0M$-18.0M$-21.0M$-50.0M$-14.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.81
FCF Yield-2166134.19%
Quick Ratio0.81
Interest Coverage-5.06
Return 1Y0.00%
Return 3Y0.00%
Return 5Y

Ownership

Insiders Held0.00%
Institutions Held0.12%
Institutions Float Held0.12%
Institutional HolderSharesReport Date
Psi Advisors, Llc59,0002025-09-30

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPEAmpio Pharmaceuticals, Inc. $0.18 +0.00% -0.02 $207884 0.00%
BLMSBloomios, Inc. $0.00 $19341 0.00%
BTTXBetter Therapeutics, Inc. $0.00 0.00 $5452 0.00%
CENBFCEN Biotech, Inc. $0.00 0.00 $6526 0.00%
DMSIDermisonics, Inc. $0.00 0.00 $1917 0.00%

About IMRIS Inc.

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Minnetonka, Minnesota.

IMRIS Inc. is led by CEO Marc Buntaine, employs 121 people, headquartered in Minnetonka, US, publicly traded since 2023.

the stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, IMRIS Inc. generates a return on equity (ROE) of -250.00%, return on capital employed of -68.54%, an operating margin of -79.31%, a net profit margin of -103.45%.

Official website: www.imris.com

Related — Stocks

BNY $152.52 -2.54% CIEN $412.39 +2.14% CBRS $188.61 -5.28% HEI.A AIRCRAFT ENGINES & ENGINE PARTS $216.35 +0.00% LEN.B GENERAL BLDG CONTRACTORS - RESIDENTIAL BLDGS $80.32 +0.00% WSO.B WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES $453.37 +0.00% MKC.V MISCELLANEOUS FOOD PREPARATIONS & KINDRED PRODUCTS $51.78 +0.00% MOG.B MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $322.00 +0.00% MOG.A MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT $307.91 +0.00% UHAL.B SERVICES-AUTO RENTAL & LEASING (NO DRIVERS) $45.71 +0.00% TAP.A MALT BEVERAGES $47.89 +0.00% VSXY $88.68 +0.50%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides